AXGN

#2056
Axogen, Inc. Common Stock
34.4600 USD
+2.96%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
34.4600
34.4600
年范围
17.1400
35.9999
日变化
+2.96%
每月变动
+5.03%
6个月变化
+88.93%
年变化
+88.93%
前一天收盘价
33.4700
开盘价
34.4600
买价
卖价
最低价
34.4600
High
34.4600
交易量
111
展开完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 1.7884 B
  • Employee 622
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-96.26
市销率
6.69

Axogen Inc

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

新闻